Status:
WITHDRAWN
Blood Flow Restriction Therapy Improves Tibial Plateau Fracture Recovery
Lead Sponsor:
Medical College of Wisconsin
Conditions:
Tibial Plateau Fractures
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to investigates the effectiveness of physical therapy augmented with blood flow restriction (BFR) therapy relative to standard physical therapy in patients after an ...
Detailed Description
Standardized Surveys: Participants will complete two patient reported functional outcome assessments via questionnaires, the KOOS (Knee Injury and Osteoarthritis Outcome Score) and the PROMIS PF (Pati...
Eligibility Criteria
Inclusion
- Equal to or greater than 18 years of age
- ORIF (open reduction and internal fixation) of a closed unicondylar tibial plateau fracture
- Planning to attend physical therapy at one of the eligible Froedtert locations with BFR therapy capabilities
Exclusion
- Patient is unable to provide consent
- At time of tibial plateau fracture has evidence of a(n)
- Open fracture(s)
- Fracture(s) with associated vascular injury,
- Fracture(s) with extensive soft tissue injury preventing the ability to apply a tourniquet
- Ipsilateral or contralateral lower extremity fracture(s)
- Pelvic or spinal trauma
- History of deep venous thrombosis (DVT)
- History of peripheral vascular disease
- Body Mass Index \> 40
- Any history of condition that would affect the patient's ability to bear weight as tolerated post-operatively.
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2028
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06589115
Start Date
December 1 2025
End Date
December 31 2028
Last Update
November 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical College of Wisconsin
Milwaukee, Wisconsin, United States, 53226